Jill Roberts Center for Inflammatory Bowel Disease

Publications

Found 123 results

] Title Type Year

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

L

Longman RS, Braun D, Pellegrini S, Rice CM, Darnell RB, Albert ML. 2007. Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation.. Blood. 109(3):1113-22.

Longman RS, Remotti H, Green PH. 2011. Esophagitis dissecans superficialis.. Gastrointest Endosc. 74(2):403-4.

Lima S, Gogokhia L, Viladomiu M, Chou L, Putzel G, Jin W, Pires S, Guo C-J, Gerardin Y, Crawford CV et al.. 2021. Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.. Gastroenterology.

Lima SF, Longman RS. 2021. Eating for Two: Diet and the Microbiome in Ulcerative Colitis.. J Crohns Colitis.

Lima S, Longman RS. 2021. A Diamond in the Rough: IgA-Seq Signatures Stratify New Onset IBD.. Cell Host Microbe. 29(1):10-12.

Lewis JD, Sandler RS, Brotherton C, Brensinger C, Li H, Kappelman MD, Daniel SG, Bittinger K, Albenberg L, Valentine JF et al.. 2021. A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With Crohn's Disease.. Gastroenterology. 161(3):837-852.e9.

K

Kumar A, Kim M, Lukin DJ. 2018. Helicobacter pylori is associated with increased risk of serrated colonic polyps: Analysis of serrated polyp risk factors.. Indian J Gastroenterol. 37(3):235-242.

Kumar A, Magro C, Lukin DJ. 2020. Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease.. Gastroenterology.

Kumar A, Teslova T, Taub E, Miller JD, Lukin DJ. 2020. Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.. Dig Dis Sci.

Kumar A, Lukin D, Battat R, Schwartzman M, Mandl LA, Scherl E, Longman RS. 2020. Defining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis.. J Gastroenterol. 55(7):667-678.

Kumar A, Lukin DJ. 2020. Incident heart failure is a predictor of adverse outcomes in inflammatory bowel disease.. Eur J Gastroenterol Hepatol. 32(2):205-215.

Kothary V, Scherl EJ, Bosworth B, Jiang Z-D, Dupont HL, Harel J, Simpson KW, Dogan B. 2013. Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps.. Antimicrob Agents Chemother. 57(2):811-7.

Koczka CPhilip, Abramowitz M, Goodman AJ. 2012. The study of bone demineralization and its risk factors in an Afro-Caribbean subset of patients with inflammatory bowel disease.. Eur J Gastroenterol Hepatol. 24(7):759-61.

Kivolowitz C, Abdulhamid A, Victorio D, Castellanos J, Simpson K, Scherl E, Longman R. 2016. O-006 Expansion of Immunologically-Relevant E. Coli in the Intestinal Microbiota of Patients with IBD-Associated Spondyloarthritis Promotes Mucosal RORgt-Dependent Immunity.. Inflamm Bowel Dis. 22 Suppl 1:S3.

Kiuru M, Camp B, Adhami K, Jacob V, Magro C, Wildman H. 2015. Treatment of metastatic cutaneous Crohn disease with certolizumab.. Dermatol Online J. 21(11)

Kayal M, Ungaro RC, Riggs A, Kamal K, Agrawal M, Cohen-Mekelburg S, Axelrad J, Faye A, Scherl E, Lawlor G et al.. 2021. Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability.. Clin Gastroenterol Hepatol.

J

Jacob V, Crawford C, Cohen-Mekelburg S, Viladomiu M, Putzel GG, Schneider Y, Chabouni F, OʼNeil S, Bosworth B, Woo V et al.. 2017. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.. Inflamm Bowel Dis. 23(6):903-911.

H

Huang C, Haritunians T, Okou DT, Cutler DJ, Zwick ME, Taylor KD, Datta LW, Maranville JC, Liu Z, Ellis S et al.. 2015. Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.. Gastroenterology. 149(6):1575-86.

Hirten R, Longman RS, Bosworth BP, Steinlauf A, Scherl E. 2015. Vedolizumab and Infliximab Combination Therapy in the Treatment of Crohn's Disease.. Am J Gastroenterol. 110(12):1737-8.

Hassan-Zahraee M, Ye Z, Xi L, Baniecki MLynn, Li X, Hyde CL, Zhang J, Raha N, Karlsson F, Quan J et al.. 2021. Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis.. Inflamm Bowel Dis.

Harris A, Eswaran S, Bosworth B, Gambarin-Gelwan M, Scherl EJ. 2007. Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.. Gastroenterol Hepatol (N Y). 3(11):875-7.

G

Gu W, Wang H, Huang X, Kraiczy J, Singh PNP, Ng C, Dagdeviren S, Houghton S, Pellon-Cardenas O, Lan Y et al.. 2021. SATB2 preserves colon stem cell identity and mediates ileum-colon conversion via enhancer remodeling.. Cell Stem Cell.

Gordon BL, Galati J, Yang S, Katz PO, Scherl EJ. 2020. Vitamin C Deficiency: An Under-Recognized Condition in Crohn's Disease.. ACG Case Rep J. 7(7):e00424.

Gold SL, Magro C, Scherl E. 2018. A Unique Infusion Reaction to Vedolizumab in a Patient With Crohn's Disease.. Gastroenterology. 155(4):981-982.

Gogokhia L, Buhrke K, Bell R, Hoffman B, D Brown G, Hanke-Gogokhia C, Ajami NJ, Wong MC, Ghazaryan A, Valentine JF et al.. 2019. Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.. Cell Host Microbe. 25(2):285-299.e8.